Tokyo Tape
Sign in

Kyorin Pharmaceutical

4569.TPharmaceutical
Filed as KYORIN Holdings, Inc. (2022-06–2022-06), KYORIN Holdings,Inc. (2022-08–2023-02)
Key numbers · FY ended 2026-03
Revenue¥126.3bn-2.9% YoYOperating income¥3.6bn-71.6% YoYNet income (owners)¥3.4bn-62.1% YoYTotal assets¥195.5bn+0.9% YoYEPS (basic)¥60.03-62.0% YoY

Full financial history and reports →

Stock price4569 · View chart ↗

Open the price chart on TradingView.

Latest filings
Thu, Oct 29 · JST1 filing
15:32MATERIALKyorin Pharmaceutical · Change in major shareholder
Tue, Oct 27 · JST1 filing
12:075% STAKEKyorin Pharmaceutical · Kopernik Global Investers, LLC · 8.75% → 10.09%+1.34pp
Wed, Sep 30 · JST1 filing
16:05MATERIALKyorin Pharmaceutical · Change in parent company or specified subsidiary
Wed, Aug 5 · JST2 filings
14:085% STAKEKyorin Pharmaceutical · Syochianz Co., Ltd. + 1 joint holder · 5.91%new 5.91%14:065% STAKEKyorin Pharmaceutical · Luces Co., Ltd. + 1 joint holder · 6.19%new 6.19%

All filings →

Major holders (5%+) · 4
HolderStakeChangeFiled
Kopernik Global Investers, LLC10.09%+1.34pp2026-10-27
MYKAM Co., Ltd8.64%+0.99pp2025-08-05
Luces Co., Ltd.6.19%—2026-08-05
Syochianz Co., Ltd.5.91%—2026-08-05

Each holder's own ratio from its most recent large-shareholding report.